MARRA, ANTONIO

MARRA, ANTONIO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Are all cyclin-dependent kinases 4/6 inhibitors created equal? 2019 Marra, AntonioCurigliano, Giuseppe Article (author) -
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 2022 Tarantino, PaoloAntonarelli, GabrieleBoscolo Bielo, LucaMarra, AntonioCrimini, EdoardoGiugliano, FedericaZagami, PaolaCorti, ChiaraTrapani, DarioMorganti, StefaniaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials 2021 Criscitiello, CarmenMarra, AntonioMorganti, StefaniaZagami, PaolaCurigliano, Giuseppe + Article (author) -
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 2020 Pietrantonio FRandon GRaimondi APagani FPrisciandaro MCorti FMarra ACurigliano Gde Braud F. + Article (author) -
Expression of tumor-associated antigens in breast cancer subtypes 2020 Curigliano, GiuseppeGhioni, MariacristinaMarra, AntonioTrapani, DarioCriscitiello, CarmenViale, Giuseppe + Article (author) -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 2021 Vernieri, ClaudioNichetti, FedericoMarra, AntonioRandon, GiovanniLigorio, FrancescaFerraro, EmanuelaTrapani, DarioMilani, AndreaBernocchi, OttaviaAjazi, ArtaGenerali, DanieleLosurdo, AgneseCurigliano, GiuseppePruneri, GiancarloMariani, Luigide Braud, Filippo + Article (author) -
Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study 2019 Marra, AViolati, MBroggio, FCodecà, CBlasi, MZonato, SMoneghini, LSaibene, AFelisati, G + Article (author) -
Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure 2023 Antonarelli, GCorti, CTarantino, PZagami, PMarra, ATrapani, DCurigliano, G + Article (author) -
Pharmacological management of male breast cancer 2020 Trapani D.Marra A.D'Amico P.Guerini Rocco E.Fusco N.Mazzarella L.Criscitiello C.Curigliano G. + Article (author) -
T cell Bispecific Antibodies to Bypass MHC Class I Loss in Breast Cancer 2019 Marra, AntonioCurigliano, Giuseppe Article (author) -
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 2022 Morganti, SMarra, AVenetis, KSajjadi, EAscione, LCorti, CZagami, PZattoni, LCurigliano, GFusco, NCriscitiello, C + Article (author) -
What therapies are on the horizon for HER2 positive breast cancer? 2019 Viale, GiuliaMorganti, StefaniaFerraro, EmanuelaZagami, PaolaMarra, AntonioCurigliano, Giuseppe Article (author) -